Tag: rare diseases

Andarix Pharmaceuticals CEO to Present on Building High-Value Biotechnology Companies at Outsourcing in Clinical Trials New England Conference

Oct 25, 2025

—

by

cadams

in Uncategorized

conference, oncology, personalized medicine, rare diseases, targeted therapy

FOR IMMEDIATE RELEASE October 16, 2025 Contact:Andarix Pharmaceuticals617-957-9858info@andarix.com Presentation Highlights Essential Tools and Strategies for Successful Biotech Company Formation BOSTON, MA – October 16, 2025 – Andarix Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation targeted radiotherapeutics for oncology, announced today that Chief Executive Officer Chris Adams will present on the essential tools and strategies needed…